PEROXISOMAL DISEASE CELL-LINES WITH CELLULAR PLASMALOGEN DEFICIENCY HAVE IMPAIRED MUSCARINIC CHOLINERGIC SIGNAL-TRANSDUCTION ACTIVITY AND AMYLOID PRECURSOR PROTEIN SECRETION
R. Perichon et al., PEROXISOMAL DISEASE CELL-LINES WITH CELLULAR PLASMALOGEN DEFICIENCY HAVE IMPAIRED MUSCARINIC CHOLINERGIC SIGNAL-TRANSDUCTION ACTIVITY AND AMYLOID PRECURSOR PROTEIN SECRETION, Biochemical and biophysical research communications (Print), 248(1), 1998, pp. 57-61
We tested whether alterations in membrane lipid composition associated
with peroxisomal diseases affect muscarinic cholinergic signal transd
uction activity and amyloid precursor protein (APP) secretion in cultu
red human skin fibroblasts and Chinese hamster ovary (CHO) mutants. We
found that in cell lines from patients with peroxisomal disorders whe
re plasmalogen levels were low, the low-Km GTPase activity was not ind
uced by carbachol, and APP secretion was reduced. This effect on signa
l transduction activity was not associated with decreased levels of th
e M1-muscarinic cholinergic receptor or its associated heterotrimeric
G-protein. Specifically, this decrease was associated with a plasmalog
en deficiency since a CHO cell line with only a deficit in plasmalogen
s was as severely affected as were generalized peroxisomal disorder ce
ll lines, Thus, plasmalogens appear to be implicated in muscarinic cho
linergic signal transduction and secretion of APP. These results provi
de new insights about the pathophysiology of peroxisomal diseases and
may be relevant to Alzheimer's disease where reduced plasmalogen level
s have been reported. (C) 1998 Academic Press.